GLP-1s for Cyclists and Runners: Race Weight, VO2 Max, and Under-Fueling Risk

A 49-year-old Cat 3 cyclist sits at 183 lbs and holds a 280W functional threshold power. His power-to-weight is 3.4 W/kg. He knows that dropping 12 lbs without losing watts would put him at 3.6 W/kg — and realistically, the guys winning in his age group are at 4.0+. The math is clear. The problem is that he's already lean for a non-cyclist (15% body fat), trains 10 hours a week, and hasn't been able to shift the extra weight with standard endurance-athlete approaches.

Endurance athletes are increasingly curious about GLP-1s for exactly this reason. The pure weight-loss effect is large. The performance math for power-to-weight sports is seductive. But the combination of high training volume, suppressed appetite, slowed gastric emptying, and blunted thirst drive creates a specific risk profile endurance athletes need to understand before starting.

Here's the case both ways — and the protocol that works if you decide to run it.

The performance math on paper

Endurance sports that reward low weight-to-power or weight-to-speed ratios benefit significantly from weight loss. Even modest reductions translate to measurable performance gains:

For a masters cyclist trying to move up a category, or a sub-3 marathoner trying to break a plateau, these are meaningful gains. This is why pro and elite amateur endurance athletes have quietly been paying attention.¹

The risks that are specific to endurance athletes

What endurance-specific medical sources keep flagging:²

• Under-fueling during training. GLP-1 appetite suppression + 10+ hours of weekly training = chronic caloric deficit. A Cat 3 cyclist burns 600–900 calories per hour on threshold intervals. Under-eating by 500 kcal per day for 3 months is exactly the pattern that causes RED-S (Relative Energy Deficiency in Sport).
• Blunted thirst signaling. GLP-1s modestly affect thirst perception in some users. Endurance training demands high fluid intake. The interaction is a setup for heat illness, cramping, and plasma volume issues.
• Gastric emptying during racing. Slowed gastric emptying means fuel you take during a race (gels, drinks, bars) is absorbed slower. Bonk risk increases. GI distress increases.
• Muscle loss affects endurance economy. Lost leg muscle = worse running economy and reduced sustained power output. Weight-denominator gains can be overwhelmed by absolute performance losses if the cut is poorly managed.
• Hormonal and immune effects. Prolonged low energy availability drives elevated cortisol, suppressed testosterone, reduced immune function, and increased stress fracture risk.³

WADA status: monitored, not banned

Semaglutide was added to the WADA Monitoring Program in 2024. It is not currently a prohibited substance. USADA follows WADA, so it's legal in US endurance competition today. Watch list status means:

• Not banned in or out of competition.
• WADA is collecting usage data to assess misuse patterns.
• Status could change in future annual updates — confirm before major events.
• If eventually banned, a Therapeutic Use Exemption would still allow medically indicated use.⁴

The endurance-athlete protocol

Key supplements for the endurance cut

Race Gels → Sports Drink Mix → LMNT Electrolytes → Whey Protein → Creatine 5g →

RED-S warning signs

Endurance athletes on GLP-1s who miss the under-fueling problem develop a specific symptom cluster. If any of these appear, stop the drug and see a sports physician:

• Morning resting HR elevated 10+ bpm above baseline for 3+ days.
• HRV trending downward for 2+ weeks despite rest.
• Persistent fatigue that doesn't resolve with an easy week.
• Cold intolerance (new, persistent).
• Low libido, erectile dysfunction.
• New stress reaction or fracture.
• Frequent minor illnesses (immune suppression).
• Inability to hit normal training paces/watts despite feeling "rested."
• Loss of training motivation unexplained by life factors.

Cyclists vs. runners: small differences

Cyclists tolerate GLP-1 cuts slightly better than runners because cycling is non-impact, glycogen is bike-replaceable during the ride, and power-to-weight improvements are highly visible and motivating.

Runners have more under-fueling and injury risk because running is impact-loaded (muscle loss shows up as injury faster), gastric emptying problems hurt in-race fueling more, and the running community's cultural under-fueling overlap with GLP-1 effects compounds.

For runners especially: don't run GLP-1 inside a marathon block. Off-season only, completed at least 8 weeks before your build phase.

The weight floor question

Endurance athletes often have an optimal racing weight below which performance declines rather than improves. For most masters men, this is approximately 10–12% body fat. Below this, hormonal and muscular penalties exceed weight-reduction gains.

Do not use a GLP-1 to chase a weight below your body's performance optimum. If you're already at 12% body fat, the drug isn't your answer — your ceiling is training specificity and recovery, not another few pounds.

The bottom line

For endurance athletes, GLP-1s can work — but only in a tightly controlled off-season protocol with scheduled fueling that overrides suppressed appetite, aggressive hydration that ignores blunted thirst, and a hard stop 6–8 weeks before racing.

For masters cyclists moving up categories or runners breaking through plateaus, the power-to-weight gains are real and measurable. For well-trained endurance athletes already at 12% body fat, the drug is the wrong tool — you need training specificity, not another cut.

Use it in the off-season, fuel deliberately, end it well before your goal race, and you'll capture the performance gain without ending up as a RED-S case study. Use it carelessly and you'll get slower, not faster. The endurance community's concerns are legitimate. The protocol's nuances matter more here than in any other sport.